GOLDFISCHER CARL
Insider CIK 1110780 · NONE Director · ETRM Director, 10% owner · EPZM Director, 10% owner · IMRA Director, 10% owner · GLTO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GLTO Galecto, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 1,440 | — | $0 | 1,440 | SEC↗ |
| GLTO Galecto, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 36,000 | — | $0 | 36,000 | SEC↗ |
| GLTO Galecto, Inc. | A Award deriv | 2023-06-14 | 2023-06-15 | 36,000 | — | $0 | 36,000 | SEC↗ |
| EPZM Epizyme, Inc. | D To issuer | 2022-08-12 | 2022-08-16 | 8,994 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | D To issuer | 2022-08-12 | 2022-08-16 | 13,060 | — | $0 | 8,994 | SEC↗ |
| EPZM Epizyme, Inc. | D To issuer | 2022-08-12 | 2022-08-16 | 3,380,951 | — | $0 | 0 | SEC↗ |
| GLTO Galecto, Inc. | A Award deriv | 2022-06-14 | 2022-06-15 | 36,000 | — | $0 | 36,000 | SEC↗ |
| IMRA IMARA Inc. | A Award deriv | 2022-06-02 | 2022-06-03 | 8,500 | — | $0 | 8,500 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2022-05-17 | 2022-05-19 | 41,006 | — | $0 | 41,006 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2022-05-17 | 2022-05-19 | 8,994 | — | $0 | 22,054 | SEC↗ |
| GLTO Galecto, Inc. | A Award deriv | 2021-11-17 | 2021-11-19 | 18,000 | — | $0 | 18,000 | SEC↗ |
| IMRA IMARA Inc. | A Award deriv | 2021-06-29 | 2021-06-30 | 7,728 | — | $0 | 7,728 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2021-06-11 | 2021-06-15 | 40,559 | — | $0 | 40,559 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2021-06-11 | 2021-06-15 | 8,060 | — | $0 | 13,060 | SEC↗ |
| GLTO Galecto, Inc. | A Award deriv | 2021-05-26 | 2021-05-28 | 18,000 | — | $0 | 18,000 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2020-11-11 | 2020-11-13 | 5,000 | $12.07 | $60.4K | 5,000 | SEC↗ |
| GLTO Galecto, Inc. | C Conversion deriv | 2020-11-02 | 2020-11-04 | 3,688 | — | $0 | 0 | SEC↗ |
| GLTO Galecto, Inc. | C Conversion deriv | 2020-11-02 | 2020-11-04 | 7,475 | — | $0 | 0 | SEC↗ |
| GLTO Galecto, Inc. | C Conversion deriv | 2020-11-02 | 2020-11-04 | 392,367 | — | $0 | 0 | SEC↗ |
| GLTO Galecto, Inc. | C Conversion | 2020-11-02 | 2020-11-04 | 9,587 | — | $0 | 9,587 | SEC↗ |
| GLTO Galecto, Inc. | C Conversion | 2020-11-02 | 2020-11-04 | 19,432 | — | $0 | 19,432 | SEC↗ |
| GLTO Galecto, Inc. | C Conversion | 2020-11-02 | 2020-11-04 | 1,020,036 | — | $0 | 1,020,036 | SEC↗ |
| GLTO Galecto, Inc. | A Award deriv | 2020-09-25 | 2020-11-04 | 3,688 | $27.11 | $100.0K | 3,688 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2020-05-29 | 2020-06-02 | 14,013 | — | $0 | 14,013 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 281,878 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 5,372 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 3,220,915 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 61,378 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 845,008 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 16,103 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | A Award deriv | 2020-03-16 | 2020-03-16 | 15,457 | — | $0 | 15,457 | SEC↗ |
| IMRA IMARA Inc. | C Conversion | 2020-03-16 | 2020-03-16 | 13,148 | — | $0 | 703,380 | SEC↗ |
| IMRA IMARA Inc. | C Conversion | 2020-03-16 | 2020-03-16 | 690,232 | — | $0 | 690,232 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2019-05-31 | 2019-06-07 | 17,633 | — | $0 | 17,633 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2019-02-07 | 2019-02-08 | 2,335 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2019-02-07 | 2019-02-08 | 9,340 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2019-02-07 | 2019-02-08 | 2,335 | $5.00 | $11.7K | 2,335 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2019-02-07 | 2019-02-08 | 11,675 | $9.02 | $105.3K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2019-02-07 | 2019-02-08 | 9,340 | $5.50 | $51.4K | 11,675 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2019-01-29 | 2019-01-31 | 27,705 | — | $0 | 27,705 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2018-05-18 | 2018-05-31 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2018-03-22 | 2018-03-23 | 2,870 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2018-03-22 | 2018-03-23 | 6,470 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2018-03-22 | 2018-03-23 | 5,660 | — | $0 | 9,340 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-03-22 | 2018-03-23 | 15,000 | $13.03 | $195.4K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2018-03-22 | 2018-03-23 | 5,660 | $5.50 | $31.1K | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2018-03-22 | 2018-03-23 | 9,340 | $5.00 | $46.7K | 9,340 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2018-01-24 | 2018-01-26 | 16,000 | — | $0 | 16,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2017-11-02 | 2017-11-06 | 9,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2017-11-02 | 2017-11-06 | 9,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2017-11-02 | 2017-11-06 | 18,000 | $8.66 | $155.9K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2017-11-02 | 2017-11-06 | 9,000 | $2.97 | $26.7K | 18,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2017-11-02 | 2017-11-06 | 9,000 | $1.72 | $15.5K | 9,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-09-22 | 2017-09-26 | 7,500 | — | $0 | 7,500 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-06-28 | 2017-06-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2017-06-22 | 2017-06-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ETRM EnteroMedics Inc | S Sale | 2017-05-25 | 2017-05-26 | 4,571 | $4.85 | $22.2K | 0 | SEC↗ |
| ETRM EnteroMedics Inc | S Sale | 2017-05-25 | 2017-05-26 | 97 | $4.85 | $470 | 0 | SEC↗ |
| ETRM EnteroMedics Inc | S Sale | 2017-05-25 | 2017-05-31 | 97 | $4.85 | $470 | 0 | SEC↗ |
| ETRM EnteroMedics Inc | S Sale | 2017-05-25 | 2017-05-31 | 4,571 | $4.85 | $22.2K | 0 | SEC↗ |
| ETRM EnteroMedics Inc | A Award deriv | 2017-02-08 | 2017-02-10 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2016-06-28 | 2016-06-30 | 9,000 | — | $0 | 9,000 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2016-05-19 | 2016-05-23 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ETRM EnteroMedics Inc | A Award deriv | 2016-05-04 | 2016-05-17 | 3,000 | — | $0 | 3,000 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2016-01-12 | 2016-01-12 | 10,389 | $9.00 | $93.5K | 3,380,951 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2016-01-12 | 2016-01-12 | 545,166 | $9.00 | $4.91M | 3,370,562 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2015-09-11 | 2015-09-11 | 13 | $2.77 | $36 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2015-09-11 | 2015-09-11 | 14,506 | $2.76 | $40.0K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2015-09-11 | 2015-09-11 | 948 | $2.76 | $2.6K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2015-09-10 | 2015-09-11 | 15 | $2.71 | $41 | 13 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2015-09-10 | 2015-09-11 | 15,474 | $2.71 | $41.9K | 14,506 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2015-09-10 | 2015-09-11 | 1,011 | $2.71 | $2.7K | 948 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2015-09-09 | 2015-09-11 | 905 | $2.76 | $2.5K | 1,959 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2015-09-09 | 2015-09-11 | 13,844 | $2.76 | $38.2K | 29,980 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2015-09-09 | 2015-09-11 | 13 | $2.76 | $36 | 28 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2015-07-08 | 2015-07-10 | 7,333 | — | $0 | 7,333 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2015-06-24 | 2015-06-30 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ETRM EnteroMedics Inc | A Award deriv | 2015-05-06 | 2015-06-22 | 25,000 | — | $0 | 112,498 | SEC↗ |
| ETRM EnteroMedics Inc | A Award deriv | 2015-05-06 | 2015-06-22 | 25,000 | — | $0 | 87,498 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2015-01-07 | 2015-01-08 | 9,000 | — | $0 | 9,000 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-09-04 | 2014-09-05 | 4,000 | $35.14 | $140.6K | 2,825,396 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-26 | 2014-08-28 | 196,260 | $35.14 | $6.90M | 2,829,136 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-26 | 2014-08-28 | 3,740 | $35.14 | $131.4K | 2,825,396 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-25 | 2014-08-25 | 17 | $36.40 | $619 | 2,825,396 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-25 | 2014-08-25 | 195,377 | $35.13 | $6.86M | 2,830,019 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-25 | 2014-08-25 | 3,723 | $35.13 | $130.8K | 2,826,296 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-25 | 2014-08-25 | 883 | $36.40 | $32.1K | 2,825,413 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-22 | 2014-08-25 | 125,606 | $32.46 | $4.08M | 3,027,790 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-22 | 2014-08-25 | 2,394 | $32.46 | $77.7K | 3,025,396 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-21 | 2014-08-25 | 723 | $33.04 | $23.9K | 3,153,396 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-21 | 2014-08-25 | 37,943 | $33.04 | $1.25M | 3,154,119 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2014-07-23 | 2014-07-25 | 7,333 | — | $0 | 7,333 | SEC↗ |
| ETRM EnteroMedics Inc | A Award deriv | 2014-05-07 | 2014-05-15 | 25,000 | — | $0 | 25,000 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-02-10 | 2014-02-12 | 8,727 | $29.25 | $255.3K | 3,192,062 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-02-10 | 2014-02-12 | 457,940 | $29.25 | $13.39M | 3,200,789 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2014-01-06 | 2014-01-08 | 2,870 | — | $0 | 2,870 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-12-23 | 2014-01-15 | 2,335 | — | $0 | 2,335 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-10-31 | 2013-11-01 | 6,470 | — | $0 | 6,470 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion deriv | 2013-06-05 | 2013-06-07 | 10,280,288 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion deriv | 2013-06-05 | 2013-06-07 | 195,904 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2013-06-05 | 2013-06-07 | 17,666 | — | $0 | 17,666 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2013-06-05 | 2013-06-07 | 163,549 | $15.00 | $2.45M | 3,655,612 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2013-06-05 | 2013-06-07 | 3,117 | $15.00 | $46.8K | 3,658,729 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion | 2013-06-05 | 2013-06-07 | 65,301 | — | $0 | 3,492,063 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion | 2013-06-05 | 2013-06-07 | 3,426,762 | — | $0 | 3,426,762 | SEC↗ |
| ETRM EnteroMedics Inc | A Award deriv | 2013-05-08 | 2013-05-09 | 10,000 | — | $0 | 37,500 | SEC↗ |
| ETRM EnteroMedics Inc | A Award deriv | 2012-05-09 | 2012-05-10 | 10,000 | — | $0 | 27,500 | SEC↗ |